Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 335 days ago

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 490 days ago

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 606 days ago

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 980 days ago

French Economy Recovers In Q1

The French economy avoided a technical recession in the first quarter with a marginal expansion, official data revealed on Wednesday. Gross domestic product grew 0.1 percent from the fourth quarter, when the economy shrank 0.1 percent, flash data from the statistical office INSEE revealed. The rate came in line with expectations.

RTTNews | 1h 12min ago

European Shares May Struggle For Direction At Open

European stocks are seen opening mixed on Wednesday as investors await key tech earnings and economic readings for direction.

RTTNews | 1h 29min ago

Sensex, Nifty Marginally Higher In Lackluster Trade

Indian shares struggled for director on Wednesday as investors watched the latest developments on the trade front and awaited key U.S. inflation data for additional clues on the Fed's rate trajectory.

RTTNews | 2h 48min ago

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Wednesday, adding to the gains in the previous four sessions, with the benchmark S&P/ASX 200 moving up to near the 8,100 level, following the broadly positive cues from Wall Street overnight, with gains financial and technology stocks partially offset by weakness in energy stocks.

RTTNews | 3h 40min ago

EURUSD	1.13828	GBPUSD	1.33971	AUDUSD	0.64029
USDJPY	142.641	USDCAD	1.38308	USDCHF	0.82467

Reklāma

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs